Business Analytics in Life Sciences: The Time is Ripe for a Technology Revamp in Clinical Trials – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Business Analytics in Life Sciences” report to their offering. The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies
Source: BusinessWire-Primary

Business Analytics in Life Sciences: The Time is Ripe for a Technology Revamp in Clinical Trials – Research and Markets